Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease

Dogru-Abbasoglu S., Inceoglu M., Parildar-Karpuzoglu H., Hanagasi H. A., Karadag B., Gurvit H., ...More

NEUROSCIENCE LETTERS, vol.404, no.3, pp.258-261, 2006 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 404 Issue: 3
  • Publication Date: 2006
  • Doi Number: 10.1016/j.neulet.2006.06.005
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.258-261
  • Keywords: Alzheimer's disease, polymorphism, DNA repair, xeroderma pigmentosum complementation group D (XPD), xeroderma pigmentosum complementation group F (XPF), NUCLEOTIDE EXCISION-REPAIR, BASAL-CELL CARCINOMA, CANCER, RISK, ADDUCTS, BRAIN, XRCC3, AGE
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No


Nucleotide excision repair (NER) is the most versatile mechanism of DNA repair, recognizing and dealing a variety of helix-distorting lesions. Xeroderma pigmentosum group D (XPD) and group F (XPF) are essential participants in NER pathway. There is evidence that two common polymorphisms of XPD gene (g.22541C > A; exon 6 and g.35931A > C; Lys > Gln; exon 23) may be associated with differential DNA repair activities. Alzheimer's disease (AD) is characterized by progressive neuronal loss correlated in time with the symptoms of disease considered. Although deficient DNA repair was proposed in the etiology of AD by several researchers, polymorphisms of DNA repair genes have not been studied in AD yet. We conducted a case-control study including 97 patients with AD and age- and sex-matched 101 control subjects to examine the role of genetic polymorphisms of XPD and XPF (g.30028T > C; exon 11) as a risk factor for AD. The frequencies of the XPD/exon 6, XPD/exon 23, and XPF/exon 11 variant alleles in our control group were 0.41, 0.35, and 0.35, respectively. No significant association was observed between the variant alleles of XPD/exon 6 (OR = 0.94, 95% CI = 0.63-1.41), XPD/exon 23 (OR = 1.24, 95% CI = 0.82-1.86) and XPF/exon I I (OR = 1.08, 95% CI = 0.72-1.64) and AD. Our results suggest that the polymorphic variants of these NER genes do not contribute to the risk of developing AD. (c) 2006 Elsevier Ireland Ltd. All rights reserved.